Home / Brands / RISING PHARMACEUTICALS
RISING PHARMACEUTICALS Recalls
9 recalls on record · March 27, 2019 to March 1, 2023 · Drugs
Recalls by year
19
20
21
22
23
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
March 1, 2023DrugsFDA
RISING PHARMACEUTICALS recalls Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663
Hazard: Failed Impurities/Degradation Specifications
March 2, 2022DrugsFDA
RISING PHARMACEUTICALS recalls Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharmaceutic
Hazard: Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.
October 13, 2021DrugsFDA
RISING PHARMACEUTICALS recalls Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma Holdings, Inc. East Bruns
Hazard: Labeling: Incorrect Instructions
July 1, 2020DrugsFDA
Rising Pharmaceuticals, Inc. recalls Timolol Maleate Sterile Opthalmic Solution,USP 0.25%, 5 mL, Rx Only, For Topical Application, Distributed by: Rising Pha
Hazard: Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had the outer carton for Timolol Maleate Sterile Ophthalmic solution USP 0.5%, 5ml but the bottle inside was Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml.
July 1, 2020DrugsFDA
Rising Pharmaceuticals, Inc. recalls Timolol Maleate USP, 0.5%, 5 mL, Sterile Opthalmic Solution, Rx Only, For Topical Application in the Eye, Distributed
Hazard: Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had the outer carton for Timolol Maleate Sterile Ophthalmic solution USP 0.5%, 5ml but the bottle inside was Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml.
March 27, 2019DrugsFDA
Rising Pharmaceuticals, Inc. recalls Valsartan Tablets 320 mg USP, 90 tablet bottles, Distributed by: Acetris Health, LLC, Saddle Brook, NJ 07663, Manufactur
Hazard: CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products
March 27, 2019DrugsFDA
Rising Pharmaceuticals, Inc. recalls Valsartan Tablets 160 mg USP, 90 tablet bottles, Rx only, Distributed by: Acetris Health, LLC, Saddle Brook, NJ 07663, M
Hazard: CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products
March 27, 2019DrugsFDA
Rising Pharmaceuticals, Inc. recalls Valsartan Tablets 80 mg USP, 90 tablet bottles, Rx only, Distributed by: Acetris Health, LLC, Saddle Brook, NJ 07663, M
Hazard: CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products
March 27, 2019DrugsFDA
Rising Pharmaceuticals, Inc. recalls Valsartan Tablets 40 mg USP, 30 tablet bottles, Rx, Only, Distributed by: Acetris Health, LLC, Saddle Brook, NJ, Manufa
Hazard: CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products